Chemoinformaics analysis of 3-(6-METHYLHEPT-5-EN-2-YL)-6-METHYLIDENECYCLOHEXENE
| Molecular Weight | 204.357 | nRot | 4 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 15 |
| Exact Molecular Weight | 204.188 | nRing | 1 |
| Solubility: LogS | -1.453 | nHRing | 0 |
| Solubility: LogP | 0.691 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.674 |
| Synth | 3.249 |
| Natural Product Likeliness | 0.376 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.13 |
| HIA | 0.01 |
| CACO-2 | -4.411 |
| MDCK | 0.000024 |
| BBB | 0.981 |
| PPB | 0.630344 |
| VDSS | 1.391 |
| FU | 0.478974 |
| CYP1A2-inh | 0.119 |
| CYP1A2-sub | 0.392 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.723 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.637 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.855 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.271 |
| CL | 5.468 |
| T12 | 0.582 |
| hERG | 0.024 |
| Ames | 0.391 |
| ROA | 0.926 |
| SkinSen | 0.581 |
| Carcinogencity | 0.904 |
| EI | 0.23 |
| Respiratory | 0.896 |
| NR-Aromatase | 0.033 |
| Antiviral | Yes |
| Prediction | 0.79814 |